Table 3.

Placebo‐corrected change from baseline QTcF (ddQTcF) at each timepoint (cardiodynamic population)

Timepoint postdose, h)	Durlobactam 4 g	Moxifloxacin 400 mg
1.5	0.7 ± 1.2 (−1.3, 2.7)	0.7 ± 1.2 (−1.4, 2.7)
3	0.5 ± 1.3 (−1.6, 2.7)	−0.3 ± 1.3 (−2.5, 1.8)
3.25	0.4 ± 1.4 (−2.0, 2.8)	0.2 ± 1.4 (−2.2, 2.6)
3.5	0.1 ± 1.4 (−2.3, 2.6)	0.3 ± 1.4 (−2.1, 2.7)
4	1.6 ± 1.4 (−0.8, 4.0)	9.9 ± 1.4 (7.5, 12.3)
5	0.5 ± 1.7 (−2.4, 3.3)	12.5 ± 1.7 (9.6, 15.3)
6	1.8 ± 1.7 (−1.0, 4.7)	13.0 ± 1.7 (10.2, 15.9)
7	1.3 ± 1.7 (−1.4, 4.1)	12.5 ± 1.7 (9.7, 15.2)
8	1.8 ± 2.8 (−2.8, 6.4)	11.1 ± 2.8 (6.4, 15.7)
12	1.3 ± 2.0 (2.1, 4.6)	10.3 ± 2.0 (7.0, 13.6)
24	0.0 ± 1.6 1.0 (−2.8, 2.7)	7.5 ± 1.6 (4.7, 10.2)